Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 91

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Does central sensitization help explain idiopathic overactive bladder?

Reynolds, W. Stuart, Dmochowski, Roger, Wein, Alan, Bruehl, Stephen · 2016 · Nature Reviews Urology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrurol.2016.95

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

15 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 166

  1. Milsom, I. et al. Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur. Urol. 65, 79–95 (2014). · DOI · Paper page
  2. Ju, R., Garrett, J. & Wu, J. M. Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States. Int. Urogynecol. J. 25, 479–484 (2014). · doi:10.1007/s00192-013-2246-0
  3. Ganz, M. L. et al. Economic costs of overactive bladder in the United States. Urology 75, 526–532.e18 (2010). · doi:10.1016/j.urology.2009.06.096
  4. Wein, A. J. Overactive bladder: defining the disease. Am. J. Manag. Care 6, S559–S564; discussion S607–S619 (2000).
  5. Abrams, P. et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol. Urodynam. 21, 167–178 (2002). · DOI · Paper page
  6. Clemens, J. Q. Afferent neurourology: a novel paradigm. Neurourol. Urodynam. 29 (Suppl. 1), S29–S31 (2010). · doi:10.1002/nau.20792
  7. Homma, Y. Hypersensitive bladder: a solution to confused terminology and ignorance concerning interstitial cystitis. Int. J. Urol. 21 (Suppl. 1), 43–47 (2014). · DOI
  8. Phillips, K. & Clauw, D. J. Central pain mechanisms in chronic pain states — maybe it is all in their head. Best Pract. Res. Clin. Rheumatol. 25, 141–154 (2011). · DOI · Paper page
  9. Yunus, M. B. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin. Arthritis Rheum. 37, 339–352 (2008). · DOI · Paper page
  10. Baron, R., Hans, G. & Dickenson, A. H. Peripheral input and its importance for central sensitization. Ann. Neurol. 74, 630–636 (2013). · DOI · Paper page
  11. Mifflin, K. A. & Kerr, B. J. The transition from acute to chronic pain: understanding how different biological systems interact. Can. J. Anaesth. 61, 112–122 (2014). · DOI
  12. Kandasamy, R. & Price, T. J. The pharmacology of nociceptor priming. Handb. Exp. Pharmacol. 227, 15–37 (2015). · DOI
  13. Kuner, R. Central mechanisms of pathological pain. Nat. Med. 16, 1258–1266 (2010). · DOI · Paper page
  14. Mizumura, K. & Murase, S. Role of nerve growth factor in pain. Handb. Exp. Pharmacol. 227, 57–77 (2015). · DOI
  15. Smith, P. A. BDNF: no gain without pain? Neuroscience 283, 107–123 (2014). · DOI
  16. Beggs, S., Trang, T. & Salter, M. W. P2X4R+ microglia drive neuropathic pain. Nat. Neurosci. 15, 1068–1073 (2012). · DOI · Paper page
  17. Old, E. A., Clark, A. K. & Malcangio, M. The role of glia in the spinal cord in neuropathic and inflammatory pain. Handb. Exp. Pharmacol. 227, 145–170 (2015). · DOI · Paper page
  18. Arendt-Nielsen, L. & Yarnitsky, D. Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera. J. Pain 10, 556–572 (2009). · DOI · Paper page
  19. Thakur, M., Dickenson, A. H. & Baron, R. Osteoarthritis pain: nociceptive or neuropathic? Nat. Rev. Rheumatol. 10, 374–380 (2014). · DOI · Paper page
  20. Roussel, N. A. et al. Central sensitization and altered central pain processing in chronic low back pain: fact or myth? Clin. J. Pain 29, 625–638 (2013). · DOI · Paper page
  21. Zhou, Q. & Verne, G. N. New insights into visceral hypersensitivity — clinical implications in IBS. Nat. Rev. Gastroenterol. Hepatol. 8, 349–355 (2011). · DOI · Paper page
  22. Kaya, S., Hermans, L., Willems, T., Roussel, N. & Meeus, M. Central sensitization in urogynecological chronic pelvic pain: a systematic literature review. Pain Physician 16, 291–308 (2013). · DOI
  23. Warren, J. W. Bladder pain syndrome/interstitial cystitis as a functional somatic syndrome. J. Psychosom. Res. 77, 510–515 (2014). · DOI
  24. Homma, Y. Hypersensitive bladder: towards clear taxonomy surrounding interstitial cystitis. Int. J. Urol. 20, 742–743 (2013). · DOI
  25. Clemens, J. Q. Afferent neurourology: an epidemiological perspective. J. Urol. 184, 432–439 (2010). · doi:10.1016/j.juro.2010.04.012
  26. Lai, H. H., Vetter, J., Jain, S., Gereau, R. W. 4th & Andriole, G. L. The overlap and distinction of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder: a questionnaire based analysis. J. Urol. 192, 1679–1685 (2014). · DOI
  27. Schur, E. A. et al. Feeling bad in more ways than one: comorbidity patterns of medically unexplained and psychiatric conditions. J. Gen. Intern. Med. 22, 818–821 (2007). · DOI
  28. Warren, J. W., Langenberg, P. & Clauw, D. J. The number of existing functional somatic syndromes (FSSs) is an important risk factor for new, different FSSs. J. Psychosom. Res. 74, 12–17 (2013). · DOI
  29. Lackner, J. M. et al. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 11, 1147–1157 (2013). · DOI
  30. Le, H. et al. Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia 31, 43–64 (2011). · DOI
  31. Bullones Rodriguez, M. A. et al. Evidence for overlap between urological and nonurological unexplained clinical conditions. J. Urol. 189, S66–74 (2013). · DOI
  32. Kim, S. E. & Chang, L. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol. Motil. 24, 895–913 (2012). · DOI
  33. Gwilym, S. E. et al. Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Arthritis Rheum. 61, 1226–1234 (2009). · DOI · Paper page
  34. Van Houdenhove, B. & Luyten, P. Central sensitivity syndromes: stress system failure may explain the whole picture. Semin. Arthritis Rheum. 39, 218–219 (2009). · DOI
  35. Cruz-Almeida, Y. & Fillingim, R. B. Can quantitative sensory testing move us closer to mechanism-based pain management? Pain Med. 15, 61–72 (2014). · DOI · Paper page
  36. Geber, C. et al. Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): a multi-centre study. Pain 152, 548–556 (2011). · DOI · Paper page
  37. Li, J., Simone, D. A. & Larson, A. A. Windup leads to characteristics of central sensitization. Pain 79, 75–82 (1999). · DOI · Paper page
  38. Chung, O. Y., Bruehl, S., Diedrich, L. & Diedrich, A. The impact of blood pressure and baroreflex sensitivity on wind-up. Anesth. Analg. 107, 1018–1025 (2008). · DOI
  39. Walker, L. S., Sherman, A. L., Bruehl, S., Garber, J. & Smith, C. A. Functional abdominal pain patient subtypes in childhood predict functional gastrointestinal disorders with chronic pain and psychiatric comorbidities in adolescence and adulthood. Pain 153, 1798–1806 (2012). · DOI · Paper page
  40. Dengler-Crish, C. M., Bruehl, S. & Walker, L. S. Increased wind-up to heat pain in women with a childhood history of functional abdominal pain. Pain 152, 802–808 (2011). · DOI
  41. Arebi, N. et al. Distinct neurophysiological profiles in irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G1086–G1093 (2011). · DOI
  42. Pfau, D. B., Rolke, R., Nickel, R., Treede, R. D. & Daublaender, M. Somatosensory profiles in subgroups of patients with myogenic temporomandibular disorders and fibromyalgia syndrome. Pain 147, 72–83 (2009). · DOI
  43. Blumenstiel, K. et al. Quantitative sensory testing profiles in chronic back pain are distinct from those in fibromyalgia. Clin. J. Pain 27, 682–690 (2011). · DOI · Paper page
  44. Smith, B. W. et al. Habituation and sensitization to heat and cold pain in women with fibromyalgia and healthy controls. Pain 140, 420–428 (2008). · DOI
  45. Larsson, M. B. et al. Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology 142, 463–472 (2012). · DOI · Paper page
  46. Cagnie, B. et al. Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. Semin. Arthritis Rheum. 44, 68–75 (2014). · DOI · Paper page
  47. Mayer, T. G. et al. The development and psychometric validation of the central sensitization inventory. Pain Pract. 12, 276–285 (2012). · DOI · Paper page
  48. Neblett, R. et al. Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample. Clin. J. Pain 31, 323–332 (2015). · DOI · Paper page
  49. Kroenke, K., Spitzer, R. L. & Williams, J. B. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom. Med. 64, 258–266 (2002). · DOI · Paper page
  50. Hauser, W., Brahler, E., Wolfe, F. & Henningsen, P. Patient Health Questionnaire 15 as a generic measure of severity in fibromyalgia syndrome: surveys with patients of three different settings. J. Psychosom. Res. 76, 307–311 (2014). · DOI
  51. Spiller, R. C. et al. The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease. Aliment. Pharmacol. Ther. 32, 811–820 (2010). · DOI · Paper page
  52. Koh, J. S. et al. Depression and somatic symptoms may influence on chronic prostatitis/chronic pelvic pain syndrome: a preliminary study. Psychiatry Investig. 11, 495–498 (2014). · DOI
  53. Kanai, A. & Andersson, K. E. Bladder afferent signaling: recent findings. J. Urol. 183, 1288–1295 (2010). · doi:10.1016/j.juro.2009.12.060
  54. Birder, L. et al. Neural control of the lower urinary tract: peripheral and spinal mechanisms. Neurourol. Urodynam. 29, 128–139 (2010). · DOI · Paper page
  55. Kanai, A. in Handbook of experimental pharmacology (eds Andersson, K. E. & Michel, M. C.) 171–206 (Springer, 2011).
  56. Chapple, C. Chapter 2: pathophysiology of neurogenic detrusor overactivity and the symptom complex of 'overactive bladder'. Neurourol. Urodynam. 33, S6–S13 (2014). · doi:10.1002/nau.22635
  57. Yoshimura, N. & de Groat, W. C. Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J. Neurosci. 19, 4644–4653 (1999). · DOI · Paper page
  58. Habler, H. J., Janig, W. & Koltzenburg, M. Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat. J. Physiol. 425, 545–562 (1990). · DOI · Paper page
  59. Mazieres, L., Jiang, C. & Lindstrom, S. The C fibre reflex of the cat urinary bladder. J. Physiol. 513, 531–541 (1998). · doi:10.1111/j.1469-7793.1998.531bb.x
  60. Xiao, Z. et al. Somatic modulation of spinal reflex bladder activity mediated by nociceptive bladder afferent nerve fibers in cats. Am. J. Physiol. Renal Physiol. 307, F673–F679 (2014). · doi:10.1152/ajprenal.00308.2014
  61. Gillespie, J. I., van Koeveringe, G. A., de Wachter, S. G. & de Vente, J. On the origins of the sensory output from the bladder: the concept of afferent noise. BJU Int. 103, 1324–1333 (2009). · doi:10.1111/j.1464-410x.2009.08377.x
  62. Keay, S. K., Birder, L. A. & Chai, T. C. Evidence for bladder urothelial pathophysiology in functional bladder disorders. BioMed Res. Int. 2014, 865463 (2014).
  63. Chacko, S., Cortes, E., Drake, M. J. & Fry, C. H. Does altered myogenic activity contribute to OAB symptoms from detrusor overactivity? ICI-RS 2013. Neurourol. Urodynam. 33, 577–580 (2014). · doi:10.1002/nau.22599
  64. Ustinova, E. E., Fraser, M. O. & Pezzone, M. A. Cross-talk and sensitization of bladder afferent nerves. Neurourol. Urodynam. 29, 77–81 (2010). · DOI
  65. Malykhina, A. P. Neural mechanisms of pelvic organ cross-sensitization. Neuroscience 149, 660–672 (2007). · DOI · Paper page
  66. Giamberardino, M. A. et al. Viscero-visceral hyperalgesia: characterization in different clinical models. Pain 151, 307–322 (2010). · DOI · Paper page
  67. Brumovsky, P. R. & Gebhart, G. F. Visceral organ cross-sensitization — an integrated perspective. Auton. Neurosci. 153, 106–115 (2010). · DOI
  68. Malykhina, A. P., Wyndaele, J. J., Andersson, K. E., De Wachter, S. & Dmochowski, R. R. Do the urinary bladder and large bowel interact, in sickness or in health? ICI-RS 2011. Neurourol. Urodynam. 31, 352–358 (2012). · DOI
  69. Minagawa, T., Wyndaele, M., Aizawa, N., Igawa, Y. & Wyndaele, J. J. Mechanisms of pelvic organ cross-talk: 2. Impact of colorectal distention on afferent nerve activity of the rat bladder. J. Urol. 190, 1123–1130 (2013). · doi:10.1016/j.juro.2013.03.079
  70. Wyndaele, M. et al. Mechanisms of pelvic organ crosstalk: 1. Peripheral modulation of bladder inhibition by colorectal distention in rats. J. Urol. 190, 765–771 (2013). · doi:10.1016/j.juro.2013.03.045
  71. Malykhina, A. P. et al. Hyperexcitability of convergent colon and bladder dorsal root ganglion neurons after colonic inflammation: mechanism for pelvic organ cross-talk. Neurogastroenterol. Motil. 18, 936–948 (2006). · DOI
  72. Rudick, C. N., Chen, M. C., Mongiu, A. K. & Klumpp, D. J. Organ cross talk modulates pelvic pain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R1191–R1198 (2007). · DOI
  73. Guo, Y. J. et al. Lower urinary tract symptoms in women with irritable bowel syndrome. Int. J. Urol. 17, 175–181 (2010). · DOI
  74. Monga, A. K., Marrero, J. M., Stanton, S. L., Lemieux, M. C. & Maxwell, J. D. Is there an irritable bladder in the irritable bowel syndrome? Br. J. Obstet. Gynaecol. 104, 1409–1412 (1997). · DOI
  75. Wyndaele, M., De Winter, B. Y., Pelckmans, P. & Wyndaele, J. J. Lower bowel function in urinary incontinent women, urinary continent women and in controls. Neurourol. Urodynam. 30, 138–143 (2011). · doi:10.1002/nau.20900
  76. Wyndaele, M. et al. Exploring associations between lower urinary tract symptoms (LUTS) and gastrointestinal (GI) problems in women: a study in women with urological and GI problems versus a control population. BJU Int. 115, 958–967 (2015). · DOI
  77. Burgers, R. et al. Functional defecation disorders in children with lower urinary tract symptoms. J. Urol. 189, 1886–1891 (2013). · doi:10.1016/j.juro.2012.10.064
  78. De Wachter, S. & Wyndaele, J. J. Impact of rectal distention on the results of evaluations of lower urinary tract sensation. J. Urol. 169, 1392–1394 (2003). · doi:10.1097/01.ju.0000053393.45026.4d
  79. Cardozo, L. & Robinson, D. Special considerations in premenopausal and postmenopausal women with symptoms of overactive bladder. Urology 60, 64–71; discussion 71 (2002). · DOI
  80. Alling Moller, L., Lose, G. & Jorgensen, T. Risk factors for lower urinary tract symptoms in women 40 to 60 years of age. Obstet. Gynecol. 96, 446–451 (2000). · DOI
  81. Klingele, C. J., Lightner, D. J., Fletcher, J. G., Gebhart, J. B. & Bharucha, A. E. Dysfunctional urinary voiding in women with functional defecatory disorders. Neurogastroenterol. Motil. 22, e1094–e1284 (2010). · DOI
  82. Carter, D. & Beer-Gabel, M. Lower urinary tract symptoms in chronically constipated women. Int. Urogynecol. J. 23, 1785–1789 (2012). · doi:10.1007/s00192-012-1812-1
  83. Coyne, K. S. et al. The prevalence of chronic constipation and faecal incontinence among men and women with symptoms of overactive bladder. BJU Int. 107, 254–261 (2011). · doi:10.1111/j.1464-410x.2010.09446.x
  84. Yamaguchi, O. et al. Defining overactive bladder as hypersensitivity. Neurourol. Urodynam. 26, 904–907 (2007). · DOI
  85. Daly, D. & Chapple, C. Relationship between overactive bladder (OAB) and irritable bowel syndrome (IBS): concurrent disorders with a common pathophysiology? BJU Int. 111, 530–531 (2013). · doi:10.1111/j.1464-410x.2013.11019.x
  86. Fitzgerald, M. P. et al. Childhood urinary symptoms predict adult overactive bladder symptoms. J. Urol. 175, 989–993 (2006). · DOI · Paper page
  87. Rodrigues, P., Hering, F. & Campagnari, J. C. Involuntary detrusor contraction is a frequent finding in patients with recurrent urinary tract infections. Urol. Intern. 93, 67–73 (2014). · doi:10.1159/000356063
  88. Saito, M. et al. Bladder dysfunction after acute urinary retention in the rats: a novel over active bladder model. Mol. Cell. Biochem. 333, 109–114 (2010). · doi:10.1007/s11010-009-0210-6
  89. Parsons, B. A. & Drake, M. J. Animal models in overactive bladder research. Handb. Exp. Pharmacol. 2011, 15–43 (2011). · DOI
  90. Fitzgerald, M. P., Koch, D. & Senka, J. Visceral and cutaneous sensory testing in patients with painful bladder syndrome. Neurourol. Urodynam. 24, 627–632 (2005). · DOI
  91. Giamberardino, M. A., Tana, C. & Costantini, R. Pain thresholds in women with chronic pelvic pain. Curr. Opin. Obstet. Gynecol. 26, 253–259 (2014). · DOI
  92. Ness, T. J., Powell-Boone, T., Cannon, R., Lloyd, L. K. & Fillingim, R. B. Psychophysical evidence of hypersensitivity in subjects with interstitial cystitis. J. Urol. 173, 1983–1987 (2005). · DOI
  93. Ness, T. J., Lloyd, L. K. & Fillingim, R. B. An endogenous pain control system is altered in subjects with interstitial cystitis. J. Urol. 191, 364–370 (2014). · DOI
  94. Fujihara, A., Ukimura, O., Iwata, T. & Miki, T. Neuroselective measure of the current perception threshold of A-delta and C-fiber afferents in the lower urinary tract. Int. J. Urol. 18, 341–349 (2011). · DOI
  95. Wenzler, D. L., Burks, F. N., Cooney, M. & Peters, K. M. Proof of concept trial on changes in current perception threshold after sacral neuromodulation. Neuromodulation 18, 228–231 (2015). · doi:10.1111/ner.12213
  96. Gleason, J. L. et al. Sacral neuromodulation effects on periurethral sensation and urethral sphincter activity. Neurourol. Urodynam. 32, 476–479 (2013). · doi:10.1002/nau.22319
  97. Vijaya, G. et al. Antimuscarinic effects on current perception threshold: a prospective placebo control study. Neurourol. Urodynam. 31, 75–79 (2012). · doi:10.1002/nau.21194
  98. Kenton, K., Lowenstein, L. & Brubaker, L. Tolterodine causes measurable restoration of urethral sensation in women with urge urinary incontinence. Neurourol. Urodynam. 29, 555–557 (2010). · doi:10.1002/nau.20804
  99. Song, Q. X., Chermansky, C. J., Birder, L. A., Li, L. & Damaser, M. S. Brain-derived neurotrophic factor in urinary continence and incontinence. Nat. Rev. Urol. 11, 579–588 (2014). · DOI
  100. Bhide, A. A., Cartwright, R., Khullar, V. & Digesu, G. A. Biomarkers in overactive bladder. Int. Urogynecol. J. 24, 1065–1072 (2013). · DOI
  101. Kim, J. C., Park, E. Y., Seo, S. I., Park, Y. H. & Hwang, T. K. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J. Urol. 175, 1773–1776; discussion 1776 (2006). · DOI · Paper page
  102. Liu, H. T., Chancellor, M. B. & Kuo, H. C. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int. 103, 1668–1672 (2009). · doi:10.1111/j.1464-410x.2009.08380.x
  103. Liu, H. T., Chancellor, M. B. & Kuo, H. C. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur. Urol. 56, 700–706 (2009). · doi:10.1016/j.eururo.2008.04.037
  104. Liu, H. T., Lin, H. & Kuo, H. C. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Neurourol. Urodynam. 30, 1525–1529 (2011). · doi:10.1002/nau.21118
  105. Wang, L. W., Han, X. M., Chen, C. H., Ma, Y. & Hai, B. Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder. Int. Urol. Nephrol. 46, 341–347 (2014). · DOI
  106. Antunes-Lopes, T., Pinto, R., Carvalho-Barros, S., Diniz, P. & Martins-Silva, C. Urinary levels of brain derived neurotrophic factor (BDNF) in women with overactive bladder (OAB) syndrome correlate with the severity of symptoms. Eur. Urol. Suppl. 10, 277–278 (2012). · doi:10.1016/s1569-9056(11)60867-1
  107. Pinto, R. et al. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur. Urol. 58, 360–365 (2010). · DOI · Paper page
  108. Griffiths, D., Tadic, S. D., Schaefer, W. & Resnick, N. M. Cerebral control of the bladder in normal and urge-incontinent women. NeuroImage 37, 1–7 (2007). · DOI · Paper page
  109. Komesu, Y. M., Ketai, L. H., Mayer, A. R., Teshiba, T. M. & Rogers, R. G. Functional MRI of the brain in women with overactive bladder: brain activation during urinary urgency. Female Pelvic Med. Reconstr. Surg. 17, 50–54 (2011). · DOI
  110. Griffiths, D. J. Use of functional imaging to monitor central control of voiding in humans. Handb. Exp. Pharmacol. 2011, 81–97 (2011). · DOI
  111. Coyne, K. S. et al. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int. 103 (Suppl. 3), 24–32 (2009). · DOI · Paper page
  112. Kaplan, S. A. et al. Systematic review of the relationship between bladder and bowel function: implications for patient management. Int. J. Clin. Pract. 67, 205–216 (2013). · DOI
  113. de Araujo, M. P. et al. Urodynamic study and quality of life in patients with fibromyalgia and lower urinary tract symptoms. Int. Urogynecol. J. Pelvic Floor Dysfunct. 19, 1103–1107 (2008). · DOI
  114. Chung, J. H. et al. The association between overactive bladder and fibromyalgia syndrome: a community survey. Neurourol. Urodynam. 32, 66–69 (2013). · DOI
  115. Brand, K., Littlejohn, G., Kristjanson, L., Wisniewski, S. & Hassard, T. The fibromyalgia bladder index. Clin. Rheumatol. 26, 2097–2103 (2007). · DOI
  116. Wassem, R., McDonald, M. & Racine, J. Fibromyalgia: patient perspectives on symptoms, symptom management, and provider utilization. Clin. Nurse Spec. 16, 24–28; discussion 29–30 (2002). · DOI
  117. White, K. P., Speechley, M., Harth, M. & Ostbye, T. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J. Rheumatol. 26, 1577–1585 (1999).
  118. Eliasson, K., Elfving, B., Nordgren, B. & Mattsson, E. Urinary incontinence in women with low back pain. Man. Ther. 13, 206–212 (2008). · DOI
  119. Matsumoto, S. et al. Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria. BJU Int. 111, 647–652 (2013). · DOI
  120. Smith, M. D., Russell, A. & Hodges, P. W. Do incontinence, breathing difficulties, and gastrointestinal symptoms increase the risk of future back pain? J. Pain 10, 876–886 (2009). · DOI
  121. Smith, M. D., Russell, A. & Hodges, P. W. Is there a relationship between parity, pregnancy, back pain and incontinence? Int. Urogynecol. J. Pelvic Floor Dysfunct. 19, 205–211 (2008). · DOI
  122. Tincello, D. G. & Walker, A. C. Interstitial cystitis in the UK: results of a questionnaire survey of members of the Interstitial Cystitis Support Group. Eur. J. Obstet. Gynecol. Reprod. Biol. 118, 91–95 (2005). · DOI
  123. Clemens, J. Q. et al. Perceptions of 'urgency' in women with interstitial cystitis/bladder pain syndrome or overactive bladder. Neurourol. Urodynam. 30, 402–405 (2011). · doi:10.1002/nau.20974
  124. Abrams, P., Hanno, P. & Wein, A. Overactive bladder and painful bladder syndrome: there need not be confusion. Neurourol. Urodynam. 24, 149–150 (2005). · doi:10.1002/nau.20082
  125. Castro-Diaz, D. et al. Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences? Int. J. Clin. Pract. 68, 356–362 (2014). · DOI
  126. Klumpp, D. J. & Rudick, C. N. Summation model of pelvic pain in interstitial cystitis. Nat. Clin. Pract. Urol. 5, 494–500 (2008). · DOI
  127. Kilpatrick, L. A. et al. Gating of sensory information differs in patients with interstitial cystitis/painful bladder syndrome. J. Urol. 184, 958–963 (2010). · DOI
  128. Twiss, C. et al. Increased startle responses in interstitial cystitis: evidence for central hyperresponsiveness to visceral related threat. J. Urol. 181, 2127–2133 (2009). · DOI
  129. Farmer, M. A. et al. Brain white matter abnormalities in female interstitial cystitis/bladder pain syndrome: A MAPP Network Neuroimaging Study. J. Urol. 194, 118–126 (2015). · DOI
  130. Clemens, J. Q., Elliott, M. N., Suttorp, M. & Berry, S. H. Temporal ordering of interstitial cystitis/bladder pain syndrome and non-bladder conditions. Urology 80, 1227–1231 (2012). · DOI
  131. Nickel, J. C. et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J. Urol. 184, 1358–1363 (2010). · DOI · Paper page
  132. Warren, J. W., Wesselmann, U., Greenberg, P. & Clauw, D. J. Urinary symptoms as a prodrome of bladder pain syndrome/interstitial cystitis. Urology 83, 1035–1040 (2014). · DOI
  133. Clemens, J. Q., Meenan, R. T., O'Keeffe Rosetti, M. C., Kimes, T. A. & Calhoun, E. A. Case–control study of medical comorbidities in women with interstitial cystitis. J. Urol. 179, 2222–2225 (2008). · DOI
  134. Warren, J. W. et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology 73, 52–57 (2009). · DOI · Paper page
  135. Wu, E. Q. et al. Interstitial cystitis: cost, treatment and co-morbidities in an employed population. PharmacoEconomics 24, 55–65 (2006).
  136. Langenberg, P. W. et al. Pelvic pain and surgeries in women before interstitial cystitis/painful bladder syndrome. Am. J. Obstet. Gynecol. 202, 286.e1–286.e6 (2010). · DOI
  137. Warren, J. W., van de Merwe, J. P. & Nickel, J. C. Interstitial cystitis/bladder pain syndrome and nonbladder syndromes: facts and hypotheses. Urology 78, 727–732 (2011). · DOI
  138. Wu, E. Q. et al. A retrospective claims database analysis to assess patterns of interstitial cystitis diagnosis. Curr. Med. Res. Opin. 22, 495–500 (2006). · DOI
  139. Kato, K., Sullivan, P. F. & Pedersen, N. L. Latent class analysis of functional somatic symptoms in a population-based sample of twins. J. Psychosom. Res. 68, 447–453 (2010). · DOI
  140. Arendt-Nielsen, L. et al. The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study. Anesth. Analg. 81, 63–68 (1995).
  141. Koppert, W. et al. A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S+-ketamine, and lidocaine. Anesthesiology 95, 395–402 (2001). · DOI · Paper page
  142. Gottrup, H. et al. Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia. Anesthesiology 101, 1400–1408 (2004). · DOI
  143. Iannetti, G. D. et al. Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. Proc. Natl Acad. Sci. USA 102, 18195–18200 (2005). · DOI · Paper page
  144. Tuchman, M., Barrett, J. A., Donevan, S., Hedberg, T. G. & Taylor, C. P. Central sensitization and CaVα2δ ligands in chronic pain syndromes: pathologic processes and pharmacologic effect. J. Pain 11, 1241–1249 (2010). · DOI
  145. Wang, H. et al. Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects. J. Pain 9, 1088–1095 (2008). · DOI
  146. Iyengar, S., Webster, A. A., Hemrick-Luecke, S. K., Xu, J. Y. & Simmons, R. M. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J. Pharmacol. Exp. Ther. 311, 576–584 (2004). · DOI · Paper page
  147. Harding, L. M., Kristensen, J. D. & Baranowski, A. P. Differential effects of neuropathic analgesics on wind-up-like pain and somatosensory function in healthy volunteers. Clin. J. Pain 21, 127–132 (2005). · DOI
  148. Kim, Y. T. et al. Gabapentin for overactive bladder and nocturia after anticholinergic failure. Int. Braz. J. Urol. 30, 275–278 (2004). · DOI
  149. Marencak, J., Cossons, N. H., Darekar, A. & Mills, I. W. Investigation of the clinical efficacy and safety of pregabalin alone or combined with tolterodine in female subjects with idiopathic overactive bladder. Neurourol. Urodynam. 30, 75–82 (2011). · doi:10.1002/nau.20928
  150. Steers, W. D. et al. Duloxetine compared with placebo for treating women with symptoms of overactive bladder. BJU Int. 100, 337–345 (2007). · doi:10.1111/j.1464-410x.2007.06980.x
  151. Di Rezze, S. et al. Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis: a pilot study. Clin. Neuropharmacol. 35, 231–234 (2012). · doi:10.1097/wnf.0b013e3182613dce
  152. Hanna-Mitchell, A. T., Kashyap, M., Chan, W. V., Andersson, K. E. & Tannenbaum, C. Pathophysiology of idiopathic overactive bladder and the success of treatment: a systematic review from ICI-RS 2013. Neurourol. Urodynam. 33, 611–617 (2014). · DOI
  153. Nitti, V. W. et al. Can we predict which patient will fail drug treatment for overactive bladder? A think tank discussion. Neurourol. Urodynam. 29, 652–657 (2010). · DOI
  154. Riedl, A. et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J. Psychosom. Res. 64, 573–582 (2008). · DOI · Paper page
  155. Gormley, E. A. et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J. Urol. 188, 2455–2463 (2012). · DOI · Paper page
  156. Newman, D. K. & Wein, A. J. Office-based behavioral therapy for management of incontinence and other pelvic disorders. Urol. Clin. North Am. 40, 613–635 (2013). · DOI
  157. Marti, B. G., Valentini, F. A. & Robain, G. Contribution of behavioral and cognitive therapy to managing overactive bladder syndrome in women in the absence of contributive urodynamic diagnosis. Int. Urogynecol. J. 26, 169–173 (2015). · doi:10.1007/s00192-014-2526-3
  158. Andersson, K. E. in Bladder Dysfunction in the Adult: The Basis for Clinical Management Current Clinical Urology (eds Wein, A. et al.) 121–220 (Springer, 2014). · DOI
  159. Thin, N. N. et al. Systematic review of the clinical effectiveness of neuromodulation in the treatment of faecal incontinence. Br. J. Surg. 100, 1430–1447 (2013). · DOI · Paper page
  160. Chodez, M. et al. Results of sacral nerve neuromodulation for double incontinence in adults. Tech. Coloproctol. 18, 1147–1151 (2014). · doi:10.1007/s10151-014-1231-z
  161. Thomas, G. P., Dudding, T. C., Rahbour, G., Nicholls, R. J. & Vaizey, C. J. Sacral nerve stimulation for constipation. Br. J. Surg. 100, 174–181 (2013). · DOI
  162. Govaert, B., Melenhorst, J., van Kleef, M., van Gemert, W. G. & Baeten, C. G. Sacral neuromodulation for the treatment of chronic functional anorectal pain: a single center experience. Pain Pract. 10, 49–53 (2010). · doi:10.1111/j.1533-2500.2009.00318.x
  163. Jadav, A. M. et al. Does sacral nerve stimulation improve global pelvic function in women? Colorectal Dis. 15, 848–857 (2013). · doi:10.1111/codi.12181
  164. Peters, K. M. Sacral neuromodulation is an effective treatment for interstitial cystitis/bladder pain syndrome: pro. J. Urol. 188, 2043–2044 (2012). · doi:10.1016/j.juro.2012.09.072
  165. Powell, C. R. & Kreder, K. J. Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J. Urol. 183, 173–176 (2010). · doi:10.1016/j.juro.2009.08.142
  166. Tirlapur, S. A., Vlismas, A., Ball, E. & Khan, K. S. Nerve stimulation for chronic pelvic pain and bladder pain syndrome: a systematic review. Acta Obstet. Gynecol. Scand. 92, 881–887 (2013). · DOI

Cited by

See all 91

Metadata

Authors
Reynolds, W. S., Dmochowski, R., Wein, A., & Bruehl, S.
Venue
Nature Reviews Urology
Published
2016-06-01
Volume
13
Issue
8
Pages
481-491
ISSN
  • 1759-4812
  • 1759-4820
Cited by
91
References
10
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.